Login / Signup

De novo design and synthesis of dipyridopurinone derivatives as visible-light photocatalysts in productive guanylation reactions.

Yameng WanHao WuNa-Na MaJie ZhaoZhiguo ZhangWenjing GaoGuisheng Zhang
Published in: Chemical science (2021)
Described here is the de novo design and synthesis of a series of 6 H -dipyrido[1,2- e :2',1'- i ]purin-6-ones (DPs) as a new class of visible-light photoredox catalysts (PCs). The synthesized DP1-5 showed their λ Abs(max) values in 433-477 nm, excited state redox potentials in 1.15-0.69 eV and -1.41 to -1.77 eV ( vs. SCE), respectively. As a representative, DP4 enables the productive guanylation of various amines, including 1°, 2°, and 3°-alkyl primary amines, secondary amines, aryl and heteroaryl amines, amino-nitrile, amino acids and peptides as well as propynylamines and α-amino esters giving diversities in biologically important guanidines and cyclic guanidines. The photocatalytic efficacy of DP4 in the guanylation overmatched commonly used Ir and Ru polypyridyl complexes, and some organic PCs. Other salient merits of this method include broad substrate scope and functional group tolerance, gram-scale synthesis, and versatile late-stage derivatizations that led to a derivative 81 exhibiting 60-fold better anticancer activity against Ramos cells with the IC 50 of 0.086 μM than that of clinical drug ibrutinib (5.1 μM).
Keyphrases
  • visible light
  • amino acid
  • induced apoptosis
  • photodynamic therapy
  • emergency department
  • gram negative
  • water soluble
  • metal organic framework
  • reduced graphene oxide
  • adverse drug
  • structural basis